Home

Anfänglich erschrocken ständig nanobodies alpaka Wolkig Zeichen freie Stelle

Llama antibody engineered to block coronavirus | National Institutes of  Health (NIH)
Llama antibody engineered to block coronavirus | National Institutes of Health (NIH)

COVID-fighting llamas inspire 'nanobody' treatments to tackle emerging  variants | Fierce Biotech
COVID-fighting llamas inspire 'nanobody' treatments to tackle emerging variants | Fierce Biotech

The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates |  eLife
The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates | eLife

Nanobody products and applications
Nanobody products and applications

Highly potent, stable nanobodies stop SARS-Co | EurekAlert!
Highly potent, stable nanobodies stop SARS-Co | EurekAlert!

Scientists develop new way to make antibodies key to research
Scientists develop new way to make antibodies key to research

Engineered llama antibodies neutralise COVID-19 virus | University of Oxford
Engineered llama antibodies neutralise COVID-19 virus | University of Oxford

Nanobodies derived from llamas, camels, and alpacas may help fight COVID-19  | Drug Discovery News
Nanobodies derived from llamas, camels, and alpacas may help fight COVID-19 | Drug Discovery News

Llama 'nanobodies' could hold key to preventing deadly post-transplant  infection | University of Cambridge
Llama 'nanobodies' could hold key to preventing deadly post-transplant infection | University of Cambridge

Expert Advice on Producing VHH Antibodies and Nanobodies
Expert Advice on Producing VHH Antibodies and Nanobodies

High affinity nanobodies block SARS-CoV-2 spike receptor binding domain  interaction with human angiotensin converting enzyme | Scientific Reports
High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme | Scientific Reports

Highly potent, stable nanobodies stop SARS-CoV-2 | Max-Planck-Gesellschaft
Highly potent, stable nanobodies stop SARS-CoV-2 | Max-Planck-Gesellschaft

Tyson the alpaca takes heavyweight role in search for coronavirus vaccine |  Reuters
Tyson the alpaca takes heavyweight role in search for coronavirus vaccine | Reuters

Highly potent, stable nanobodies stop SARS-CoV-2 | Max-Planck-Gesellschaft
Highly potent, stable nanobodies stop SARS-CoV-2 | Max-Planck-Gesellschaft

Engineered llama antibodies neutralise Covid-19 virus - - Diamond Light  Source
Engineered llama antibodies neutralise Covid-19 virus - - Diamond Light Source

NIH neuroscientists isolate promising mini antibodies against COVID-19 from  a llama | National Institutes of Health (NIH)
NIH neuroscientists isolate promising mini antibodies against COVID-19 from a llama | National Institutes of Health (NIH)

Nano-Secondaries product review
Nano-Secondaries product review

Another research group joins the llama-inspired COVID-19 antibody bandwagon  | Fierce Biotech
Another research group joins the llama-inspired COVID-19 antibody bandwagon | Fierce Biotech

Highly specific nanobody against herbicide 2,4-dichlorophenoxyacetic acid  for monitoring of its contamination in environmental water - ScienceDirect
Highly specific nanobody against herbicide 2,4-dichlorophenoxyacetic acid for monitoring of its contamination in environmental water - ScienceDirect

Alpaca nanobody neutralizes the SARS-CoV-2 spike protein
Alpaca nanobody neutralizes the SARS-CoV-2 spike protein

Deep Dive Into Alpaca's Nanobody Repertoire Identifies Potent SARS-CoV-2  Neutralizers | Technology Networks
Deep Dive Into Alpaca's Nanobody Repertoire Identifies Potent SARS-CoV-2 Neutralizers | Technology Networks

The immune system of the alpaca reveals a potential treatment for cancer |  IRB Barcelona
The immune system of the alpaca reveals a potential treatment for cancer | IRB Barcelona

NeutrobodyPlex nanobodies help monitor SARS-CoV-2 immune responses
NeutrobodyPlex nanobodies help monitor SARS-CoV-2 immune responses

A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants -  ScienceDirect
A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants - ScienceDirect

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614  variants by a monomeric, sub-nanomolar affinity nanobody | Scientific  Reports
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody | Scientific Reports